Next Article in Journal
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines
Next Article in Special Issue
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
Previous Article in Journal
Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector
Previous Article in Special Issue
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
 
 
Article

Article Versions Notes

Cancers 2018, 10(4), 126; https://doi.org/10.3390/cancers10040126
Action Date Notes Link
article xml file uploaded 21 April 2018 07:39 CEST Original file -
article xml uploaded. 21 April 2018 07:39 CEST Update https://www.mdpi.com/2072-6694/10/4/126/xml
article pdf uploaded. 21 April 2018 07:39 CEST Version of Record https://www.mdpi.com/2072-6694/10/4/126/pdf
article supplementary file uploaded. 21 April 2018 07:39 CEST - https://www.mdpi.com/2072-6694/10/4/126#supplementary
article html file updated 21 April 2018 07:40 CEST Original file -
article html file updated 1 May 2018 12:09 CEST Update -
article html file updated 29 March 2019 17:49 CET Update -
article html file updated 17 April 2019 02:16 CEST Update -
article html file updated 1 May 2019 01:42 CEST Update -
article html file updated 2 October 2019 20:14 CEST Update -
article html file updated 9 February 2020 14:44 CET Update https://www.mdpi.com/2072-6694/10/4/126/html
Back to TopTop